Xilio Therapeutics Inc
NASDAQ:XLO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
X
|
Xilio Therapeutics Inc
NASDAQ:XLO
|
US |
|
HCL Technologies Ltd
NSE:HCLTECH
|
IN |
|
MS&AD Insurance Group Holdings Inc
TSE:8725
|
JP |
Wall St Price Targets
XLO Price Targets Summary
Xilio Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for XLO is 20.4 USD with a low forecast of 20.2 USD and a high forecast of 21 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XLO's stock price target?
Price Target
20.4
USD
According to Wall Street analysts, the average 1-year price target for XLO is 20.4 USD with a low forecast of 20.2 USD and a high forecast of 21 USD.
What is the Revenue forecast for Xilio Therapeutics Inc?
Projected CAGR
-13%
The compound annual growth rate for Revenue over the next 8 years is -13%.